• Antipsychotic dose reduction compared to dose continuation for people with schizophrenia 

      Rodolico A., Siafis S., Bighelli I., Samara M.T., Hansen W.-P., Salomone S., Aguglia E., Cutrufelli P., Bauer I., Baeckers L., Leucht S. (2022)
      Background: Antipsychotic drugs are the mainstay treatment for schizophrenia, yet they are associated with diverse and potentially dose-related side effects which can reduce quality of life. For this reason, the lowest ...